Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety and Efficacy of Alitretinoin in Severe Refractory Chronic Hand Dermatitis
2005-004776-20Phase 3Completed
- Sponsor
- Basilea Pharmaceutica
- Start
- Feb 2007
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, single-arm trial of alitretinoin in chronic hand dermatitis (CHE), sponsored by Basilea Pharmaceutica. Primary endpoints: Safety of alitretinoin and Efficacy of alitretinoin. Started Feb 2007; status: completed.
02
Drugs
alitretinoin
03
Conditions
chronic hand dermatitis (CHE)
Beyond the preview
Go deeper on 2005-004776-20.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-004776-20.